XML 65 R94.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Disposition Of Pharmaceutical Product Lines And Restructuring (Details) (USD $) | 12 Months Ended | 1 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended
--- | --- | --- | --- | --- | ---
Dec. 31, 2013 | Dec. 31, 2012 | Jan. 31, 2009 | Dec. 31, 2008 | Dec. 31, 2014 | Dec. 31, 2010 | Dec. 31, 2009 | Dec. 31, 2011
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items] |  |  |  |  |  |  |  |
Proceeds from disposition of pharmaceutical product lines | $ 3,500,000 us-gaap_ProceedsFromSaleOfOtherProductiveAssets | $ 3,000,000 us-gaap_ProceedsFromSaleOfOtherProductiveAssets |  |  |  |  |  |
Acarexx And SURPASS Products And Feline Insulin Product Under Development [Member] |  |  |  |  |  |  |  |
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items] |  |  |  |  |  |  |  |
Proceeds from disposition of pharmaceutical product lines |  |  | 1,400,000 us-gaap_ProceedsFromSaleOfOtherProductiveAssets / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_AcarexxAndSurpassProductsAndFelineInsulinProductUnderDevelopmentMember | 7,000,000 us-gaap_ProceedsFromSaleOfOtherProductiveAssets / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_AcarexxAndSurpassProductsAndFelineInsulinProductUnderDevelopmentMember |  |  |  |
Royalty Bearing License Agreement [Member] |  |  |  |  |  |  |  |
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items] |  |  |  |  |  |  |  |
Proceeds from disposition of pharmaceutical product lines |  |  |  | 300,000 us-gaap_ProceedsFromSaleOfOtherProductiveAssets / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_RoyaltyBearingLicenseAgreementMember |  |  |  |
Milestone payment earned | 300,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_RoyaltyBearingLicenseAgreementMember |  |  |  | 1,600,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_RoyaltyBearingLicenseAgreementMember | 300,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_RoyaltyBearingLicenseAgreementMember |  |
Feline Insulin Product [Member] |  |  |  |  |  |  |  |
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items] |  |  |  |  |  |  |  |
Milestone payment earned |  | 3,500,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_FelineInsulinProductMember |  |  |  | 3,000,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_FelineInsulinProductMember | 2,000,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_FelineInsulinProductMember | 3,000,000 us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_FelineInsulinProductMember
Feline Insulin Product Total Potential Milestone Payments [Member] |  |  |  |  |  |  |  |
Disposition Of Pharmaceutical Product Lines And Restructuring [Line Items] |  |  |  |  |  |  |  |
Potential milestone payments |  |  |  | $ 11,500,000 us-gaap_GainContingencyUnrecordedAmount / idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis = idxx_FelineInsulinProductTotalPotentialMilestonePaymentsMember |  |  |  |

X
- Details
Name: | idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringLineItems
Namespace Prefix: | idxx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount or range of possible amounts of gain that could be realized upon the resolution of a contingency. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6397426&loc=d3e17499-108355 + Details
Name: | us-gaap_GainContingencyUnrecordedAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash inflow from the sale of other tangible or intangible assets used to produce goods or deliver services not otherwise defined in the taxonomy. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 + Details
Name: | us-gaap_ProceedsFromSaleOfOtherProductiveAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of consideration recognized during the period for the milestone or milestones. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 28 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=19771982&loc=SL6892177-166501 + Details
Name: | us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis=idxx_AcarexxAndSurpassProductsAndFelineInsulinProductUnderDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis=idxx_FelineInsulinProductMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis=idxx_FelineInsulinProductTotalPotentialMilestonePaymentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | idxx_DispositionOfPharmaceuticalProductLinesAndRestructuringAxis=idxx_RoyaltyBearingLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |